Product
DS-5141b
2 clinical trials
1 indication
Indication
Duchenne muscular dystrophyClinical trial
Phase I/II Study of DS-5141b: Open-label Study of DS-5141b in Patients With Duchenne Muscular DystrophyStatus: Completed, Estimated PCD: 2020-10-20
Clinical trial
A Phase II, Long-term, Extension Study of DS-5141b in Patients With Duchenne Muscular DystrophyStatus: Active (not recruiting), Estimated PCD: 2027-01-31